Phase I trial of multiple ascending doses of BAL 30072 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 25 Oct 2011
At a glance
- Drugs BAL 30072 (Primary)
- Indications Gram-negative infections
- Focus Adverse reactions; Pharmacokinetics
- 25 Oct 2011 Results published in the Basilea Pharmaceutica media release.
- 25 Oct 2011 Status changed from recruiting to completed, according to a Basilea Pharmaceutica media release.
- 08 Sep 2011 New trial record